Inventor · disambiguated record
Sharon Cload
Also filed as: CLOAD SHARON · CLOAD SHARON T
22 granted patents·8 pending applications·551 citations·filing 1998–2023
97Inventor score
Files withBRISTOL MYERS SQUIBB CO17CLOAD SHARON3ANADYS PHARMACEUTICALS INC2ARCHEMIX CORP1CAMPHAUSEN RAY1
Top patents by PatentIndex Score
30 records- 0197US9662373B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 30, 2017·27 cites·31 claims
- 0297US8420098B2Fibronectin based scaffold domain proteins that bind to PCSK9CAMPHAUSEN RAY·Filed 2011·Granted Apr 16, 2013·86 cites·8 claims
- 0396US8933199B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 13, 2015·36 cites·36 claims
- 0496US8853154B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 7, 2014·35 cites·15 claims
- 0595US8993265B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 31, 2015·27 cites·11 claims
- 0694US9540424B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 10, 2017·27 cites·19 claims
- 0794US8969289B2Serum albumin binding moleculesGOSSELIN MICHAEL L·Filed 2011·Granted Mar 3, 2015·45 cites·33 claims
- 0894US8101385B2Materials and methods for the generation of transcripts comprising modified nucleotidesCLOAD SHARON·Filed 2007·Granted Jan 24, 2012·113 cites·24 claims
- 0993US10221438B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 5, 2019·12 cites·16 claims
- 1093US9493546B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·14 cites·20 claims
- 1192US9856309B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·10 cites·16 claims
- 1291US10947297B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 16, 2021·5 cites·19 claims
- 1391US10934572B2Serum albumin binding moleculesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 2, 2021·4 cites·16 claims
- 1490US9234027B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 12, 2016·10 cites·22 claims
- 1588US6569628B2Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·16 cites·9 claims
- 1687US2024316161A1Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1786US2024239870A1Fibronectin based scaffold domain proteins that bind pcsk9BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1883US10406212B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 10, 2019·2 cites·11 claims
- 1980US6331392B1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsANADYS PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·29 cites·9 claims
- 2078US10245302B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·17 claims
- 2178US7579450B2Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeuticsARCHEMIX CORP·Filed 2005·Granted Aug 25, 2009·4 cites·20 claims
- 2277US11813315B2Fibronectin based scaffold domain proteins that bind to myostatinBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 14, 2023·0 cites·20 claims
- 2376US11858979B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 2, 2024·0 cites·10 claims
- 2472US6335339B1Triazine antiviral compoundsSCRIPTGEN PHARM INC·Filed 1999·Granted Jan 1, 2002·48 cites·14 claims
- 2561US2003152992A1Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acidsFiled 2003·Application pending·0 cites
- 2654US2003228603A1Compositions selective for caffeine or aspartame and methods of using sameFiled 2003·Application pending·0 cites
- 2745US2004018515A1Compositions selective for adenosine diphosphate and methods of using sameFiled 2003·Application pending·0 cites
- 2843US2009075342A1Metabolic profile directed aptamer medicinal chemistryCLOAD SHARON·Filed 2008·Application pending·0 cites
- 2941US2009018093A1Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease TherapeuticsCLOAD SHARON·Filed 2005·Application pending·0 cites
- 3039US2004126882A1Regulatable, catalytically active nucleic acidsELLINGTON ANDREW D·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →